SPP1 and congenital bilateral aplasia of vas deferens from CFTR mutation: In summary, we identified that LRRC15 and SPP1 could serve as inflammation‐associated candidate hub genes or potential therapeutic targets in CAVD and OA using bioinformatics and machine learning.